FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic AdenocarcinomaAmro M. Abdelrahman, Mark J. Truty, Jennifer L. Leiting et al.|Journal of the National Comprehensive Cancer Network|2022Cited by 59
Circulating Tumor DNA Predicts Early Recurrence Following Locoregional Therapy for Oligometastatic Colorectal CancerC. O'Donnell, Zhaohui Jin, Nikolas Naleid et al.|Cancers|2024Cited by 4